Importantly, ISG15 has been demonstrated to promote resistance to DNA-damaging chemo- and radiotherapy in different cancer types and to be correlated with unfavorable prognosis100, suggesting the potential of targeting ISG15 for resensitization of tumor cells and improvement of the outcome of anticancer therapy. Here, ISG15 is linked to neoplasm.